Recombinant Human LRP12 (C-6His)

Description

EnkiLife provides the Recombinant Human LRP12 (C-6His) protein,aslo know as Low-Density Lipoprotein Receptor-Related Protein 12,LRP-12,Suppressor of Tumorigenicity 7 Protein,LRP12,ST7, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Low-Density Lipoprotein Receptor-Related Protein 12 is produced by our Mammalian expression system and the target gene encoding Glu33-Ile488 is expressed with a 6His tag at the C-terminus.Accession:Q9Y561. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:52.48 KDa. Background:Low-Density Lipoprotein Receptor-Related Protein 12 (LRP12) belongs to the LDLR family. LRP12 is a type I transmembrane protein annd widely expressed in heart, skeletal muscle, brain, lung, placenta and pancreas. LRP12 contains 2 CUB domain and 5 LDL-receptor class A domain. LRP12 has been shown to interact with GNB2L1, ZFYVE9 and ITGB1BP3. LRP12 is a receptor probably, which may be involved in the internalization of lipophilic molecules and/or signal transduction. In addition, LRP12 may act as a tumor suppressor.